Purple Innovation, Inc. current report, 14 August 2020

Business Context and Reporting Period

Purple Innovation, Inc. (PRPL) filed this Form 8-K on August 14, 2020, reporting the entry into a material definitive agreement. The company is an emerging growth company incorporated in Delaware.

Key Financial Metrics

This filing does not report standard financial performance metrics such as revenue, profit, cash flow, or margins. The primary financial disclosure relates to a specific transaction:

  • Transaction Consideration: The Company paid $8,456,191 to acquire intellectual property rights.
  • Liquidity/Debt: No specific data on debt levels or liquidity positions is provided in this text.

Material Changes

The material change involves the acquisition of a license and intellectual property from EdiZONE, LLC, an entity indirectly controlled by two members of the Company's Board of Directors (Tony Pearce and Terry Pearce). Key changes include:

  • License Transfer: Acquisition of all interests in the License Agreement with Advanced Comfort Technologies, Inc. (ACTI), a domestic competitor.
  • Revenue Rights: The Company is now the direct licensor entitled to all future royalties paid by ACTI, which have been increasing due to ACTI's rising sales.
  • Trademark Assignment: Acquisition of the "GEL MATRIX" and "INTELLIPILLOW" trademarks.

Outlook, Risks, and Contingencies

Management Commentary: The transaction secures royalty streams from a competitor (ACTI) that sells through similar retail channels.

Risks and Contingencies:

  • Indemnification Obligation: The Company must indemnify EdiZONE against claims by ACTI regarding breaches of the License Agreement, claims arising from the execution of the new Agreement, or issues related to the Company's ownership and enforcement of the License Agreement.
  • Related Party Transaction: The counterparty is controlled by Board members, presenting potential conflict of interest considerations.

Investor Verification Checklist

  • Verify the full terms of the License Transfer and IP Assignment Agreement in the upcoming 10-Q filing.
  • Assess the historical and projected royalty revenue from ACTI to determine the return on the $8.46 million investment.
  • Review the specific indemnification clauses to understand the potential liability exposure regarding ACTI claims.
  • Confirm the related party transaction disclosures and Board approval processes.